Page 26 - பல்கலைக்கழகம் ஆஃப் ஹைடெல்பெர்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CET- Comunicado - ;ultimaHoraHtml += + json.lead + ;}ultimaHoraHtml += ; document.getElementById( urgente ).innerHTML = ultimaHoraHtml; } } }); COMUNICADO: Merck and BioMed X Institute Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity - MERCK KGAA/PR NEWSWIRE - Merck to support up to six additional research projects at the BioMed X Institute in Heidelberg within the next six years - Call for application for a global crowdsourcing project, Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging DARMSTADT, Germany, May 17, 2021 /PRNewswire/ Merck, a leading science and technology company, today announced the extension of its ongoing collaboration with BioMed X, Heidelberg, Germany. Under the new agreement, Merck will start up to six additional research projects at the BioMed X Institute, building on ongoing research projects in the fields of oncology (DNA damage response and RNA splic

United statesBaden wübergJoern peter hallePrnewswire merckChristian tidonaGlobal head of researchMerck pressBiomedx institute in heidelbergUniversity of heidelbergBiomedx instituteRegulatoryt cell dysfunctionGlobal headNature biotechnologyManaging directorMerck press releasesஒன்றுபட்டது மாநிலங்களில்